Aurobindo Expects Interim Phase II/III COVID-19 Vaccine Data By July

Biosimilars Development Progresses

 
• By Vibha Ravi
Ampule, vials, pharmaceutical factory
Aurobindo Creating Vaccine, API Manufacturing Capacity • Source: Shutterstock

More from R&D

More from Scrip